MG

Markus Gude

IP Idorsia Pharmaceuticals: 3 patents #3 of 37Top 9%
📍 Allschwil, CH: #4 of 56 inventorsTop 8%
Overall (2018): #65,926 of 503,207Top 15%
3
Patents 2018

Issued Patents 2018

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
10023560 Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist Christoph Boss, Christine Brotschi, Bibia Heidmann, Thierry Sifferlen, Markus Von Raumer +1 more 2018-07-17
9914720 Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists Christoph Boss, Christine Brotschi, Bibia Heidmann, Thierry Sifferlen, Markus Von Raumer +1 more 2018-03-13
9914721 Use of benzimidazole-proline derivatives Christoph Boss, Catherine Roch, Christine Brotschi, Bibia Heidmann, François Jenck +3 more 2018-03-13